To address this, we transduced CD34+ BC CML cells with lentiviral shRNA constructs and achieved efficient and specific downregulation of either RAC1 or RAC2 (S1 Fig). The gene discussed is RAC1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.